Expert Angle Webinars: 2018

The Ins (Brachytherapy) and Outs (External Beam) of Prostate Radiotherapy with Dr. Danny Vesprini

January 16, 2018

This presentation is focused on explaining how radiation therapy works and describes the two main methods of delivering prostate radiotherapy - brachytherapy and external beam radiotherapy. It reviews the main treatment options for low, intermediate and high risk prostate cancer, focusing on the radiotherapy options. This is a video that men and their families may find useful in explaining the different types of radiation and some of the reasons why one modality may be preferred compared to the other options.
 

The Ins and Outs of Radical Prostatectomy with Dr. Peter Black

January 30, 2018

The objective of this presentation is to educate patients, their partners and their loved ones to learn about radical prostatectomy as a treatment option for prostate cancer. We will discuss what the surgery entails and what to expect during the early recovery period. This will include consideration of possible complications of surgery and the need for sexual and bladder rehabilitation after surgery. Finally we will also discuss additional cancer therapies that may be offered after radical prostatectomy and how patients are followed to ensure they remain cancer free.
 

Choosing What’s Right for You: Comparing Common Side Effects of Prostate Cancer Treatment with Dr. Danny Vesprini

February 13, 2018

This presentation is an overview of the most common and serious side effects that are possible for men who are treated for prostate cancer.  It compares and contrasts the 4 main treatment options: surgery, low dose rate (LDR; permanent seed) brachytherapy, high dose rate (HDR: temporary seed) brachytherapy, and external beam radiotherapy (EBRT).   This is a presentation that men and their families who are still undecided as to what treatment option they prefer may find useful as it compares the risk of developing a side effect of therapy (e.g. bladder leaking, rectal bleeding, etc) between the four options.  This presentation is based on the best available data in the medical literature that a collaborative group of surgeons and oncologists agreed upon to help make sure patients are provided consistent, high quality information.
 

Why do prostate cancers become resistant to treatment? with Dr. Paul Toren

February 27, 2018

Prostate cancer which has spread outside of the prostate gland is treated with systemic therapy. However, these treatments are not curative. Understanding the biological reasons for why these treatments do not work or become ineffective is important to identify better ways to treat patients. This presentation will give an overview of current understanding of why prostate cancers develop resistance to current therapies.
 

It's a Couples' Thing: Prostate Cancer and Its Impact on Sexuality and Quality of Life with Dr. Anne Katz

March 13, 2018

This short webinar will address key aspects of the impact of prostate cancer treatment on the couple. It is widely acknowledged that treatment for prostate cancer results in sexual side effects that impact both the man and his partner. These side effects often impact on the couple's relationship in a negative way and cause distress for both individuals. This webinar will address what these issues are as well as making suggestions to mitigate the effects on the couple.

 

The changing landscape: Understanding non-metastatic (m0) castration resistant prostate cancer with Dr. Robert Hamilton

March 29, 2018

This presentation takes a closer look at a critical time within the prostate cancer disease journey between the localized and advanced disease state. Metastasis, when the cancer spreads to a different part of the body, is currently targeted by multiple treatment options available in the market. With the recent SPARTAN and PROSPER clinical trials, there are new drug developments that may target the non-metastatic castration resistant prostate cancer window to further delay metastases. Key tools and imaging options in detecting metastases are also discussed.
 

Prostate Cancer 101 with Dr. Scott North

April 17, 2018

This webinar will focus on describing what the prostate is and what it does.  Risk factors for the development of prostate cancer will be described as well as what symptoms and signs might be present that would give a clue to abnormalities of prostate health, including cancer.  If cancer is suspected, a brief description of what diagnostic tests might be needed will be reviewed as well as next steps after a diagnosis of prostate cancer is established.
 

Economic Evaluation 101: Another piece of evidence with Dr. Wanrudee Isaranuwatchai

May 1, 2018

The ability to apply economic thinking when making a choice or a decision can be important partly because of limited resources which we are faced with in health care. This webinar will introduce participants to economic evaluation and its potential to help us understand the value of health intervention. Economic evaluation is a technique which enables users to compare two or more health interventions or to quantify a potential impact of a health initiative through an economic lens. Economic evaluation could provide another piece of evidence to assist various groups such as health providers, decision-makers, and policy-makers in their decision-making process.
 

Prevention & Modifiable Risk Factors with Dr. Carla Prado

May 15, 2018

In this webinar, Dr. Carla Prado discusses the findings of a recently conducted review on diet and lifestyle factors that were found to influence the risk of prostate cancer. A list of the strongest risk and protective factors against prostate cancer are reviewed along with strategies for maintaining a healthy lifestyle. Furthermore, current guidelines for healthy living, including Canada’s Food Guide, are broken down so they can be implemented into your daily life.

 

Sexual Dysfunction with Dr. Dean Elterman

May 29, 2018

This webinar reviews the sexual side effects that may occur after prostate cancer treatment. The risk factors of post-prostatectomy erectile dysfunction, recovery time and the benefits and limitations of available treatments will be described including the use of PDE5 inhibitors, vacuums, injections and other devices. 


 

Importance of Muscle Mass to Survivorship with Dr. Carla Prado

June 13, 2018

Research indicates that low muscle mass is a powerful and independent predictor of poorer health outcomes in the general public, particularly for those affected by cancer. In this webinar, Dr. Carla Prado discusses what leads to muscle loss, how you can prevent muscle loss with proper nutrition and what unique variables need to be considered for prostate cancer patients. Dr. Prado breaks down some of the essential nutrients for the maintenance of strong bones and muscle mass by providing simple guidelines on healthy eating.
 

Pharmacotherapy for Patients with Advanced and Metastatic Prostate Cancer with Dr. Andrew Feifer

June 26, 2018

This webinar is an introduction to common drug treatments available for advanced and metastatic prostate cancer. Dr. Andrew Feifer discusses the role of testosterone and the androgen receptor in the development and growth of prostate cancer. Further, Dr. Feifer will discuss the efficacy and side effects of these drug based treatments including hormone therapy and novel therapies for castration resistant prostate cancer. 









Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
1.5 million Canadian men over 50 now at unnecessary risk for prostate cancer

Toronto (ON) – September 26, 2019 – New findings released today in a Prostate Cancer Canada nationwide survey suggest 1.
More

$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground
More

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.
More

Researchers discover common markers of tumour hypoxia across 19 cancer types

Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumours
More

Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More


Click here for news archive